Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan vs enalapril to prevent doxorubicin + trastuzumab cardiotoxicity in breast cancer
IRCT20180722040556N11Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer and Cardiotoxicity comparing Sacubitril/valsartan arm with Enalapril arm (2 arms). Started Feb 2025; status: completed.
02
Drugs
sacubitril + valsartanenalapril
03
Conditions
breast cancerCardiotoxicity
Beyond the preview
Go deeper on IRCT20180722040556N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180722040556N11.